4-carboxyphenylglycine has been researched along with Brain Ischemia in 2 studies
4-carboxyphenylglycine: RN given for (+-)-isomer; RN for cpd without isomeric designation not available 3/93; glutamate receptor antagonist
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Soria, FN | 1 |
Pérez-Samartín, A | 1 |
Martin, A | 1 |
Gona, KB | 1 |
Llop, J | 1 |
Szczupak, B | 1 |
Chara, JC | 1 |
Matute, C | 1 |
Domercq, M | 1 |
Henrich-Noack, P | 1 |
Reymann, KG | 1 |
2 other studies available for 4-carboxyphenylglycine and Brain Ischemia
Article | Year |
---|---|
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.
Topics: Amino Acid Transport System y+; Animals; Benzoates; Brain Ischemia; Cell Death; Glutamate Plasma Mem | 2014 |
(1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia.
Topics: Animals; Benzoates; Brain Ischemia; Cell Count; Cell Survival; Cycloleucine; Dose-Response Relations | 1999 |